The genetic diversity among globally circulating human immunodeficiency virus type 1 (HIV-1) strains is a serious challenge for HIV-1 vaccine design. We have generated a synthetic group M consensus env gene (CON6) for induction of cross-subtype immune responses and report here a comparative study of T-cell responses to this and natural strain env immunogens in a murine model. Three different strains of mice were immunized with CON6 as well as subtype A, B, or C env immunogens, using a DNA prime-recombinant vaccinia virus boost strategy. T-cell epitopes were mapped by gamma interferon enzyme-linked immunospot analysis using five overlapping Env peptide sets from heterologous subtype A, B, and C viruses. The CON6-derived vaccine was im...
AbstractHIV-1 diversity has been considered a huge challenge for the HIV-1 vaccine development. To o...
HIV-1 diversity has been considered a huge challenge for the HIV-1 vaccine development. To overcome ...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
The genetic diversity among globally circulating human immunodeficiency virus type 1 (HIV-1) strains...
The genetic diversity among globally circulating human immunodeficiency virus type 1 (HIV-1) strains...
The genetic diversity among globally circulating human immunodeficiency virus type 1 (HIV-1) strains...
Consensus HIV-1 genes can decrease the genetic distances between candidate immunogens and field viru...
Consensus HIV-1 genes can decrease the genetic distances between candidate immunogens and field viru...
The extreme genetic diversity of the human immunodeficiency virus type 1 (HIV-1) poses a daunting ch...
The extreme genetic diversity of the human immunodeficiency virus type 1 (HIV-1) poses a daunting ch...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
AbstractHIV-1 subtype C is the most common HIV-1 group M subtype in Africa and many parts of Asia. H...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
AbstractHIV-1 diversity has been considered a huge challenge for the HIV-1 vaccine development. To o...
HIV-1 diversity has been considered a huge challenge for the HIV-1 vaccine development. To overcome ...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
The genetic diversity among globally circulating human immunodeficiency virus type 1 (HIV-1) strains...
The genetic diversity among globally circulating human immunodeficiency virus type 1 (HIV-1) strains...
The genetic diversity among globally circulating human immunodeficiency virus type 1 (HIV-1) strains...
Consensus HIV-1 genes can decrease the genetic distances between candidate immunogens and field viru...
Consensus HIV-1 genes can decrease the genetic distances between candidate immunogens and field viru...
The extreme genetic diversity of the human immunodeficiency virus type 1 (HIV-1) poses a daunting ch...
The extreme genetic diversity of the human immunodeficiency virus type 1 (HIV-1) poses a daunting ch...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
AbstractHIV-1 subtype C is the most common HIV-1 group M subtype in Africa and many parts of Asia. H...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
AbstractHIV-1 diversity has been considered a huge challenge for the HIV-1 vaccine development. To o...
HIV-1 diversity has been considered a huge challenge for the HIV-1 vaccine development. To overcome ...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...